Relative Efficacy of Alirocumab, Bempedoic Acid, Evolocumab, Ezetimibe and Inclisiran Added to Statins for Reduction of Low Density Lipoprotein Cholesterol - A Network Meta-Analysis of Randomized Clinical Trials

被引：0
|
作者：
Toth, Peter P.
Bray, Sarah
Worth, Gavin
机构：
来源：
CIRCULATION | 2020年 / 142卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A13503
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Network Meta-Analysis of Randomized Trials Evaluating the Comparative Efficacy of Lipid-Lowering Therapies Added to Maximally Tolerated Statins for the Reduction of Low-Density Lipoprotein Cholesterol
    Toth, Peter P.
    Bray, Sarah
    Villa, Guillermo
    Palagashvili, Tamara
    Sattar, Naveed
    Stroes, Erik S. G.
    Worth, Gavin M.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2022, 11 (18):
  • [2] Meta Analysis of Efficacy and Safety of Bempedoic Acid in Lowering Low Density Lipoprotein Cholesterol
    Khan, Muhammad U.
    Khan, Safi U.
    Khan, Muhammad
    Lone, Ahmad Naeem
    Valavoor, Shahul
    Raghu, Charumathi
    Arshad, Adeel
    Talluri, Swapna
    Alkhouli, Mohamad Adnan
    CIRCULATION, 2019, 140
  • [3] Efficacy and safety of alirocumab and evolocumab: a systematic review and meta-analysis of randomized controlled trials
    Guedeney, Paul
    Giustino, Gennaro
    Sorrentino, Sabato
    Claessen, Bimmer E.
    Camaj, Anton
    Kalkman, Deborah N.
    Vogel, Birgit
    Sartori, Samantha
    De Rosa, Salvatore
    Baber, Usman
    Indolfi, Ciro
    Montalescot, Gilles
    Dangas, George D.
    Rosenson, Robert S.
    Pocock, Stuart J.
    Mehran, Roxana
    EUROPEAN HEART JOURNAL, 2022, 43 (07) : E17 - E25
  • [4] Clinical efficacy and safety of evolocumab for low-density lipoprotein cholesterol reduction
    Henry, Courtney A.
    Lyon, Ronald A.
    Ling, Hua
    VASCULAR HEALTH AND RISK MANAGEMENT, 2016, 12 : 163 - 169
  • [5] Efficacy and safety of different doses of alirocumab in reducing low-density lipoprotein cholesterol levels: a network meta-analysis
    Pan, Ruirong
    Li, Yanyan
    Zhou, Hongwen
    PHARMAZIE, 2019, 74 (01): : 8 - 14
  • [6] Comparative Efficacy of Colchicine and Intensive Low-density Lipoprotein Cholesterol Lowering in Patients with Atherosclerotic Diseases receiving Statins: A Network Meta-analysis of Randomized Controlled Trials
    Ou, Zhenhong
    Wang, Fangchao
    Chen, Yunlin
    Liu, Xueyuan
    Ran, Boli
    Yin, Yuehui
    Cui, Kun
    CARDIOVASCULAR DRUGS AND THERAPY, 2024,
  • [7] Low density lipoprotein cholesterol, statins and cardiovascular events:: a meta-analysis
    Genser, B.
    Maerz, W.
    CLINICAL RESEARCH IN CARDIOLOGY, 2006, 95 (08) : 393 - 404
  • [8] Efficacy and safety of different doses of evolocumab in reducing low-density lipoprotein cholesterol levels: A meta-analysis
    Cheng, Cheng
    Sun, Sijia
    Zhou, Yafeng
    Yang, Xiangjun
    BIOMEDICAL REPORTS, 2016, 5 (05) : 541 - 547
  • [9] Impact of alirocumab/evolocumab on lipoprotein (a) concentrations in patients with familial hypercholesterolaemia: a systematic review and meta-analysis of randomized controlled trials
    Dai, Haibing
    Zhu, Yonglin
    Chen, Zuyi
    Yan, Renqing
    Liu, Jinsong
    He, Ziyun
    Zhang, Lin
    Zhang, Feng
    Yan, Shengkai
    ENDOKRYNOLOGIA POLSKA, 2023, 74 (03) : 234 - 242
  • [10] Indirect comparison of the safety and efficacy of alirocumab and evolocumab: from a comprehensive meta-analysis of 30 randomized controlled trials
    Guedeney, P.
    Sorrentino, S.
    Giustino, G.
    Chapelle, C.
    Claessen, B.
    Ollier, E.
    Laporte, S.
    Camaj, A.
    Kalkman, D. N.
    Vogel, B.
    De Rosa, S.
    Indolfi, C.
    Collet, J. P.
    Mehran, R.
    Montalescot, G.
    EUROPEAN HEART JOURNAL, 2019, 40 : 3260 - 3260
12345